HR-Positive, HER2-Negative Metastatic Breast Cancer

Published: July 2021
  Looking for subscriptions?

A digital version of this pocket guide is available for FREE at this link

  • Introduction
  • Figure
    • Algorithm for Endocrine Treatment and Targeted Therapy for HR positive, HER2 negative Metastatic Breast Cancer
  • For purchases under 100 in quantity, we suggest placing the order directly through the website.
  • We offer group/institutional licenses for multi-user accounts (discount amount varies depending on the number of users).
  • We are proud to offer special discounts to medical schools, training programs, students and more.
  • We offer bulk purchase discounts based on number of copies and number of titles.

Contact Us for more details

Founded in 1964, the American Society of Clinical Oncology is the world's leading professional organization for physicians and oncology professionals caring for people with cancer.

Description

This pocket guide attempts to define principles of practice that should produce high-quality patient care. It is applicable to specialists, primary care, and providers at all levels. This pocket guide should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. The ultimate judgment concerning the propriety of any course of conduct must be made by the clinician after consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool.

Price:$9.95

Digital Download Information:
  • Supported on Apple and Android devices
  • Content is accessible offline
  • PDF Format
  • Download instantly from your account
Clear
Need help?